Interim measures by the Autorité de la Concurrence: history repeats itself after IMS Health
Pablo Ibañez Colomo (Chilling Competition)
Last week’s decision by the Autorité de la Concurrence is remarkable for several reasons, in particular because it provides for interim measures and it is about exploitative conduct. In that sense, it is an excellent example of what the new competition law will bring.
Traditional competition law was reluctant to engage with practices involving the administration of complex, prescriptive remedies (such as the redesign of a product or the determination of the terms and conditions under which firms are to deal with rivals and/or customers).
The decision reveals how much things are changing. As summarised in the picture above, the Autorité does not hesitate to mandate that Google set up a framework for its negotiations with press publishers and their remuneration.
At the same time, the decision feels like a déjà vu. When reading it, I could not avoid being reminded of the interim measures adopted by the Commission in IMS Health back in 2001 (and the subsequent developments before the then Court of First Instance)…
Featured News
Subscribers Defend $4.7 Billion Antitrust Verdict Against NFL in Court Filings
Jul 19, 2024 by
CPI
Von der Leyen Calls for Competition Policy to Boost EU Companies’ Growth
Jul 19, 2024 by
CPI
Vermont AG Sues Pharmacy Benefit Managers Over Drug Prices
Jul 18, 2024 by
CPI
Australians Face Increased Stamp Prices Following ACCC Approval
Jul 18, 2024 by
CPI
Live Nation Seeks Dismissal of DOJ Antitrust Allegations
Jul 18, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Private Equity Roll-Up Schemes
Jun 28, 2024 by
CPI
The FTC’s Focus on Private Equity is Warranted
Jun 28, 2024 by
CPI
Unraveling the Roll-Up: Private Equity’s Misunderstood Investment Strategy
Jun 28, 2024 by
CPI
Antitrust Focus on Private Equity Funds and Serial Acquisitions
Jun 28, 2024 by
CPI
Private Equity Roll-Ups Amidst Heightened Antitrust Enforcement
Jun 28, 2024 by
CPI